Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibody

M Garkavij, J Tennvall, S E Strand, H O Sjögren, C JianQing, R Nilsson, M Isaksson
1997 Journal of Nuclear Medicine  
This study investigates the efficacy of tumor radioimmunotargeting with 125I-labeled BR96-biotin monoclonal antibody using a new method, whole-blood immunoadsorption (WBIA), based on direct adsorption of unbound monoclonal antibody (MAb) from blood without preceding separation of plasma.
pmid:9189138 fatcat:ayipyhojbjgazbnmhriwamlmzm